home / stock / rtgn / rtgn short
Short Information | RetinalGenix Technologies Inc Com (OTCMKTS:RTGN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,320 |
Total Actual Volume | 2,868 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 16 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 116 |
Average Short Percentage | 79.39% |
Is there a RTGN Short Squeeze or Breakout about to happen?
See the RTGN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-22-2024 | $3.5 | $3.5 | $3.5 | $3.5 | 400 | 400 | 100% |
01-10-2024 | $3.1 | $3.1 | $3.1 | $3.1 | 100 | 100 | 100% |
11-07-2023 | $3 | $3.09 | $3.09 | $3 | 400 | 400 | 100% |
09-11-2023 | $3 | $3 | $3 | $3 | 212 | 200 | 94.34% |
08-28-2023 | $0 | $9.4 | $0 | $0 | 20 | 20 | 100% |
08-08-2023 | $0 | $9.4 | $0 | $0 | 8 | 5 | 62.5% |
05-19-2023 | $0 | $9.4 | $0 | $0 | 4 | 4 | 100% |
04-12-2023 | $0 | $9.4 | $0 | $0 | 101 | 50 | 49.5% |
04-06-2023 | $0 | $9.4 | $0 | $0 | 60 | 30 | 50% |
04-03-2023 | $0 | $9.4 | $0 | $0 | 32 | 7 | 21.88% |
03-23-2023 | $0 | $9.4 | $0 | $0 | 29 | 20 | 68.97% |
03-21-2023 | $0 | $9.4 | $0 | $0 | 19 | 19 | 100% |
02-10-2023 | $0 | $9.4 | $0 | $0 | 30 | 30 | 100% |
02-07-2023 | $0 | $9.4 | $0 | $0 | 10 | 10 | 100% |
11-14-2022 | $9 | $9 | $9 | $9 | 100 | 100 | 100% |
09-28-2022 | $20 | $20 | $20 | $20 | 100 | 100 | 100% |
08-25-2022 | $8 | $8 | $10 | $8 | 200 | 200 | 100% |
07-26-2022 | $0 | $0 | $0 | $0 | 80 | 25 | 31.25% |
07-14-2022 | $7.1 | $7.15 | $7.15 | $7.1 | 334 | 100 | 29.94% |
07-12-2022 | $8 | $7.1 | $8 | $7.1 | 629 | 500 | 79.49% |
News, Short Squeeze, Breakout and More Instantly...
RetinalGenix Technologies Inc Com Company Name:
RTGN Stock Symbol:
OTCMKTS Market:
RetinalGenix Technologies Inc Com Website:
PETALUMA, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“ RetinalGeniX ” or the “Company”), today announced that it has contracted with MEDsan, Inc. (“MEDsan” to provide diagnostic testing services ...
PETALUMA, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB: RTGN) (“RetinalGeniX” or the “Company”), today announced that Anatoly Dritschilo, M.D. has joined the Company’s Medical Advisory Board. RetinalGeniX is an ophthalmic...
PETALUMA, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB: RTGN) (“RetinalGeniX” or the “Company”), today announced that Dessislava (Dessy) Boneva, M.D. has joined the Company’s Board of Directors. RetinalGeniX is an ophthal...